Maria J Pajares

Maria J Pajares

UNVERIFIED PROFILE

Are you Maria J Pajares?   Register this Author

Register author
Maria J Pajares

Maria J Pajares

Publications by authors named "Maria J Pajares"

Are you Maria J Pajares?   Register this Author

41Publications

1253Reads

45Profile Views

Complement C4d-specific antibodies for the diagnosis of lung cancer.

Oncotarget 2018 Jan 26;9(5):6346-6355. Epub 2017 Dec 26.

Program in Solid Tumors, Center for Applied Medical Research (CIMA), CIBERONC, and Navarra's Health Research Institute (IDISNA), Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.23690DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814217PMC
January 2018

Erratum to: Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.

Respir Res 2017 06 2;18(1):113. Epub 2017 Jun 2.

Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Ctra. del Rosario 145, 38010, Santa Cruz de Tenerife, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12931-017-0589-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455076PMC
June 2017

Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.

Respir Res 2017 04 13;18(1):59. Epub 2017 Apr 13.

Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Ctra. del Rosario 145, 38010, Santa Cruz de Tenerife, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12931-017-0547-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390353PMC
April 2017

Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma.

Oncotarget 2016 Dec;7(51):85063-85078

Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), Universidad Autónoma de Madrid, Cantoblanco, Madrid.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356720PMC
December 2016

A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.

Mol Oncol 2016 11 9;10(9):1437-1449. Epub 2016 Aug 9.

Program in Solid Tumors and Biomarkers, CIMA, 31008 Pamplona, Spain; Department of Biochemistry and Genetics, School of Science, University of Navarra, 31008 Pamplona, Spain; Navarra's Health Research Institute (IDISNA), 31008 Pamplona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423218PMC
November 2016

A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.

Clin Cancer Res 2016 07 3;22(13):3361-71. Epub 2016 Feb 3.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2346DOI Listing
July 2016

Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.

PLoS One 2015 27;10(4):e0124670. Epub 2015 Apr 27.

Biomarkers Laboratory, Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, 31008 Pamplona, Spain; Navarra's Health Research Institute (IDISNA), Pamplona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0124670PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411155PMC
February 2016

TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

Cancer Lett 2016 Jan 4;370(2):165-76. Epub 2015 Nov 4.

Department of Histology and Pathology, School of Medicine, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain; Program of Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.10.012DOI Listing
January 2016

Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.

Eur J Cancer 2015 Sep 30;51(14):1897-903. Epub 2015 Jul 30.

Program in Solid Tumor and Biomarkers, Center for Applied Medical Research, University of Navarra, Pamplona 31008, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.07.015DOI Listing
September 2015

Phosphoinositide 3-kinase p85beta regulates invadopodium formation.

Biol Open 2014 Sep 12;3(10):924-36. Epub 2014 Sep 12.

Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), Campus de Cantoblanco, Madrid E-28049, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/bio.20148185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197441PMC
September 2014

TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.

Mol Cancer Res 2014 May 24;12(5):660-9. Epub 2014 Feb 24.

Authors' Affiliations: Oncology Division, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona; 2Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain; 3Nuffield Department of Clinical Laboratory Sciences; 4Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital; 5Department of Medical Oncology, University of Oxford, The Churchill Hospital, Oxford, United Kingdom; 6Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Jinan, China; and 7Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-13-0481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207305PMC
May 2014

Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.

Cancer Res 2014 Feb 26;74(4):1105-15. Epub 2013 Dec 26.

Authors' Affiliations: Division of Oncology, Center for Applied Medical Research (CIMA); Departments of Histology and Pathology and Biochemistry and Genetics, Schools of Science and Medicine, University of Navarra, Pamplona; and CEIT and TECNUN, University of Navarra, San Sebastian, Spain.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/early/2013/12/24/0
Web Search
http://cancerres.aacrjournals.org/content/74/4/1105.full.pdf
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-1481DOI Listing
February 2014

A prognostic DNA methylation signature for stage I non-small-cell lung cancer.

J Clin Oncol 2013 Nov 30;31(32):4140-7. Epub 2013 Sep 30.

Juan Sandoval, Jesus Mendez-Gonzalez, F. Javier Carmona, Sergi Sayols, Sebastian Moran, Holger Heyn, Miguel Vizoso, Antonio Gomez, Montse Sanchez-Cespedes, and Manel Esteller, Bellvitge Biomedical Research Institute; Josefina Mora, Hospital de la Santa Creu i Sant Pau; Manel Esteller, University of Barcelona and Institucio Catalana de Recerca i Estudis Avançats, Barcelona; Miquel Taron and Rafael Rosell, Catalan Institute of Oncology, Badalona, Catalonia; Marina Pollan, Instituto de Salud Carlos III, Madrid; Maria J. Pajares and Luis M. Montuenga, University of Navarra; Wenceslao Torre, Clínica University de Navarra, Pamplona, Spain; Ernest Nadal, Guoan Chen, and David G. Beer, University of Michigan Medical School, Ann Arbor, MI; Yassen Assenov and Fabian Müller, Max Planck Institute, Saarbrücken, Germany; Christoph Bock, Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Lucia A. Muscarella, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Triantafillos Liloglou, Michael Davies, and John K. Field, The University of Liverpool Cancer Research Centre, Liverpool, United Kingdom; Elisabeth Brambilla, Centre Hospitalier Universitaire A Michallon, Grenoble, France; Luca Roz, IRCCS Foundation National Cancer Institute, Milan; Marco Lo Iacono and Giorgio V. Scagliotti, University of Torino, Orbassano (Torino), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5516DOI Listing
November 2013

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

J Natl Cancer Inst 2013 Sep 12;105(18):1385-93. Epub 2013 Aug 12.

Affiliations of authors: Division of Oncology, Center for Applied Medical Research, Pamplona, Spain (DA, MJP, LC, JA, LMM, RP); Department of Histology and Pathology (MJP, JA, LMM) and Department of Biochemistry and Genetics (RP) School of Medicine, University of Navarra, Pamplona, Spain; Department of Oncology (JLP), Department of Pathology (MDL), Department of Thoracic Surgery (WT), Department of Pulmonary Medicine (JPdT, JJZ) Clínica Universidad de Navarra, Pamplona, Spain; Thoracic Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN (PPM); Department of Medicine, University of Valencia, Valencia, Spain (CC); Department of Medical Oncology, Hospital General Universitario de Valencia, Valencia, Spain (CC); Molecular Oncology Laboratory, Fundación para la Investigación del Hospital General Universitario de Valencia, Valencia, Spain (EJL).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776260PMC
September 2013

Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.

Int J Cancer 2013 May 20;132(9):1986-95. Epub 2012 Oct 20.

Oncology Division, Center for Applied Medical Research (CIMA), University of Navarra, 55 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27881DOI Listing
May 2013

Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.

Clin Cancer Res 2012 Feb 5;18(4):969-80. Epub 2012 Jan 5.

Adhesion and Metastasis Laboratory, Biomarkers Laboratory, Division of Oncology, Center for Applied Biomedical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1686DOI Listing
February 2012

Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.

Clin Cancer Res 2011 Jun 3;17(12):4155-66. Epub 2011 May 3.

Departments of Oncology, Pathology, and Thoracic Surgery, Clínica Universidad de Navarra; Division of Oncology, Center for Applied Medical Research (CIMA), Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-3381DOI Listing
June 2011

Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.

Cancer Epidemiol Biomarkers Prev 2010 Oct 27;19(10):2665-72. Epub 2010 Aug 27.

Division of Oncology, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-0467DOI Listing
October 2010

The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.

Clin Cancer Res 2010 Aug 3;16(16):4113-25. Epub 2010 Aug 3.

Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0076DOI Listing
August 2010

TGFBI expression is associated with a better response to chemotherapy in NSCLC.

Mol Cancer 2010 May 28;9:130. Epub 2010 May 28.

Division of Oncology, Center for Applied Medical Research, Universidad de Navarra, Pío XII 55, Pamplona, 31008, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-9-130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900244PMC
May 2010

Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells.

Int J Cancer 2008 Apr;122(7):1512-20

Division of Oncology, CIMA, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.23236
Publisher Site
http://dx.doi.org/10.1002/ijc.23236DOI Listing
April 2008

Alternative splicing: an emerging topic in molecular and clinical oncology.

Lancet Oncol 2007 Apr;8(4):349-57

Oncology Division, Centre for Applied Medical Research, School of Medicine, University of Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(07)70104-3DOI Listing
April 2007

Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features.

Cancer Epidemiol Biomarkers Prev 2006 Feb;15(2):373-80

Oncology Division, Center for Applied Medical Research, Clínica Universitaria de Navarra, Pamplona, Spain.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-0
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-05-0320DOI Listing
February 2006